p16^ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load

Authors: Kreuter, A.; Wieland, U.¹; Gambichler, T.; Altmeyer, P.; Pfister, H.¹; Tenner-Racz, K.²; Racz, P.²; Potthoff, A.; Brockmeyer, N.H.

Source: British Journal of Dermatology, Volume 157, Number 3, September 2007 , pp. 523-530(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary Background

Human papillomavirus (HPV)-associated anogenital cancers and their precursor lesions occur in excess in human immunodeficiency virus (HIV)-infected patients despite the initiation of highly active antiretroviral therapy. In this context, a drastically increased relative risk for anal intraepithelial neoplasia (AIN) exists in HIV-infected men having sex with men (MSM). In a pilot study, imiquimod, a topical immune response modifier, has been reported to be beneficial in the treatment of AIN. Objectives

To investigate the role of several biomarkers as potential adjuncts in the course of imiquimod treatment for AIN, and to determine whether these markers correlate with the course of high-risk HPV DNA load during imiquimod therapy. Methods

Immunohistochemical staining was performed for p16^ink4a, minichromosome maintenance protein (MCM), Ki67, proliferating cell nuclear antigen (PCNA) and p21^waf1 expression before and after 16 weeks of imiquimod treatment for AIN. High-risk HPV DNA load determinations were performed by real-time polymerase chain reaction with type-specific primers and probes for HPV types 16, 18, 31 and 33. Results

Histopathological and virological analyses were performed in 21 HIV-infected MSM with histologically confirmed AIN. Eighteen (86%) patients had a complete histological clearance of AIN after imiquimod therapy. As previously shown, lesional high-risk HPV DNA load significantly decreased during imiquimod therapy. Moreover, a significant decline of p16^ink4a, Ki67, MCM and PCNA expression after treatment was observed, while p21^waf1 expression changed nonsignificantly after imiquimod therapy. A significant correlation between the course of high-risk HPV DNA load and p16^ink4a expression was observed during imiquimod treatment of AIN, whereas the decline of high-risk HPV DNA load did not significantly correlate with MCM, Ki67, PCNA or p21^waf1 expression. Conclusions

The significant decrease in p16^ink4a expression in correlation with the drop of lesional high-risk HPV load suggests that p16^ink4a may be a useful adjunct for the evaluation of treatment response in HPV-associated malignancies and their precursor lesions.

Keywords: anal intraepithelial neoplasia; human immunodeficiency virus infection; human papillomavirus DNA load; human papillomavirus infection; p16ink4a; proliferative biomarkers

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2133.2007.08004.x

Affiliations: 1: Institute of Virology, University of Cologne, Cologne, Germany 2: Bernhard-Nocht Institute for Tropical Diseases, Hamburg, Germany

Publication date: 2007-09-01